HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 30, 30994-31001, July 23, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/30/30994    most recent M403697200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Y.-M. Articles by Rock, C. O. Search for Related Content PubMed PubMed Citation Articles by Zhang, Y.-M. Articles by Rock, C. O. Social Bookmarking                      What's this?

Evaluation of Epigallocatechin Gallate and Related Plant Polyphenols as Inhibitors of the FabG and FabI Reductases of Bacterial Type II Fatty-acid Synthase^*

Yong-Mei Zhang and Charles O. Rock

From the Protein Science Division, Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105

Epigallocatechin gallate (EGCG) is the major component of green tea extracts and possesses antibacterial, antiviral, and antitumor activity. Our study focused on validating the inhibition of the bacterial type II fatty acid synthesis system as a mechanism for the antibacterial effects of EGCG and related plant polyphenols. EGCG and the related tea catechins potently inhibited both the FabG and FabI reductase steps in the fatty acid elongation cycle with IC₅₀ values between 5 and 15 µM. The presence of the galloyl moiety was essential for activity, and EGCG was a competitive inhibitor of FabI and a mixed type inhibitor of FabG demonstrating that EGCG interfered with cofactor binding in both enzymes. EGCG inhibited acetate incorporation into fatty acids in vivo, although it was much less potent than thiolactomycin, a validated fatty acid synthesis inhibitor, and overexpression of FabG, FabI, or both did not confer resistance. A panel of other plant polyphenols was screened for FabG/FabI inhibition and antibacterial activity. Most of these inhibited both reductase steps, possessed antibacterial activity, and inhibited cellular fatty acid synthesis. The ability of the plant secondary metabolites to interfere with the activity of multiple NAD(P)-dependent cellular processes must be taken into account when assessing the specificity of their effects.

Received for publication, April 2, 2004 , and in revised form, April 27, 2004.

^* This work was supported by National Institutes of Health Grant GM34496, Cancer Center (CORE) Support Grant CA 21765, and the American Lebanese Syrian Associated Charities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794. Tel.: 901-495-3491; Fax: 901-495-3099; E-mail: charles.rock{at}stjude.org.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. J. Zheng, M.-J. Sohn, and W.-G. Kim Vinaxanthone, a new FabI inhibitor from Penicillium sp. J. Antimicrob. Chemother., May 1, 2009; 63(5): 949 - 953. [Abstract] [Full Text] [PDF]

				C. E. Isaacs, G. Y. Wen, W. Xu, J. H. Jia, L. Rohan, C. Corbo, V. Di Maggio, E. C. Jenkins Jr., and S. Hillier Epigallocatechin Gallate Inactivates Clinical Isolates of Herpes Simplex Virus Antimicrob. Agents Chemother., March 1, 2008; 52(3): 962 - 970. [Abstract] [Full Text] [PDF]

				A. K. Brown, A. Papaemmanouil, V. Bhowruth, A. Bhatt, L. G. Dover, and G. S. Besra Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II Microbiology, October 1, 2007; 153(10): 3314 - 3322. [Abstract] [Full Text] [PDF]

				J. S. Freundlich, F. Wang, H.-C. Tsai, M. Kuo, H.-M. Shieh, J. W. Anderson, L. J. Nkrumah, J.-C. Valderramos, M. Yu, T. R. S. Kumar, et al. X-ray Structural Analysis of Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase as a Pathway toward the Optimization of Triclosan Antimalarial Efficacy J. Biol. Chem., August 31, 2007; 282(35): 25436 - 25444. [Abstract] [Full Text] [PDF]

				S. Wolfram Effects of Green Tea and EGCG on Cardiovascular and Metabolic Health J. Am. Coll. Nutr., August 1, 2007; 26(4): 373S - 388S. [Abstract] [Full Text] [PDF]

				Y.-M. Zhang, S. W. White, and C. O. Rock Inhibiting Bacterial Fatty Acid Synthesis J. Biol. Chem., June 30, 2006; 281(26): 17541 - 17544. [Abstract] [Full Text] [PDF]